News & Updates

In men with prostate cancer and concomitant atherosclerotic cardiovascular disease (ASCVD), major adverse cardiovascular event (MACE) incidence did not differ between those who were treated with degarelix or leuprolide, according to findings of the PRONOUNCE trial.

In individuals with type 2 diabetes (T2D), the glucagon-like peptide-1 receptor agonist (GLP1-RA) liraglutide appeared to yield a cardioprotective benefit, data from the secondary endpoint analysis of the LIRAFLAME* trial suggests.

Cardiac manifestations, such as acute myocardial infarction (AMI) and myocarditis, after vaccination for the coronavirus disease 2019 (COVID-19) are more common in men, according to a recent Singapore study. AMI is more likely to arise after the first shot, while myocarditis becomes more common after the second dose.

Women on menopausal hormone therapy are at risk of developing hypertension, particularly those using oral oestrogen plus a progestogen such as pregnane and norpregnane derivatives, according to a study.

Smoking increases the risk of venous thromboembolism (VTE) in cancer patients, but not in people without cancer, a recent study has found.

In the treatment of women with acute ischaemic stroke, mechanical thrombectomy is effective and can be safely performed during pregnancy or the postpartum period, as shown in a study.

Long-term exposure to night shift work is associated with risks of atrial fibrillation (AF) and coronary heart disease (CHD), a study suggests.

Individuals with rosacea are at heightened risk of developing subsequent cardiovascular disease, as suggested in a study.

Individuals with mental disorders, specifically schizophrenia, receive fewer screening and lower-quality treatment for cardiovascular disease (CVD), reveals a study.